University of Wisconsin, Madison
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).
University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.
University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.
Top-decile sponsor footprint
University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,039 total, page 2 of 21
The AHA Oneida Study
NCT07139132
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 2
NCT06601699
The RECAP2 Study: Midazolam and Psilocybin
NCT06692192
Worldwide Yearly Screening for Hypospadias
NCT06966375
The Advancing Dynamic And Personalized Training Study
NCT07051330
Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care
NCT06643598
Community-based Implementation of Adapted STAC
NCT06689930
The Options 2 Study
NCT06595459
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
NCT06257082
Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)
NCT06981156
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
NCT06924021
Improving Show Rates in Dental Care Settings Serving Underserved Populations
NCT06581250
A Trial to Improve Family Clinical Note Access and Outcomes for Hospitalized Children
NCT06722378
Neuroplasticity Biomarkers in Aphasia
NCT06471127
qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver
NCT06971991
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
NCT06122610
Femoral BMD Change Following Cemented or Cementless Total Knee Arthroplasty
NCT06733597
Celecoxib for ENT Pain Management
NCT06505187
PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study
NCT06811935
Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage
NCT06342375
The ENHANCE Study: taVNS and Psilocybin
NCT05866471
Speech Pattern Evaluation and Analysis for Knowledge of AD
NCT06230783
Implementation of a Primary Hospital Provider (PHP) Team
NCT06581224
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
NCT06601686
Effects of E-cigarette Use on Health
NCT06610838
PDA for Kidneys Study
NCT06658496
Characterization of Fetal Lung With Quantitative Ultrasound
NCT06722365
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
NCT06608511
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
NCT06162624
Well-being Training for Adolescent Depressive Symptoms (TeenWell Study)
NCT06626425
FDG PET/MR Imaging of Peripheral Pain Generators
NCT06171659
Improving Surgical Communication for Patients in Wisconsin
NCT06647303
A Pilot Study of Local Anesthesia for Inguinal Hernia Surgery in Older Adults
NCT04706026
Cognitive Behavioral and Faith Fellowship to Improve Thy Health
NCT06292637
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
NCT06392711
Effectiveness of Cognitive Training in Older and Younger Adults
NCT06375681
Study of 18F-FFNP Breast PET/MRI
NCT06086704
The Avenues Study: Dual Use Cessation
NCT06474299
Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma
NCT06308913
Growing Little PEAPODS Study
NCT06226051
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease
NCT06380075
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
NCT06527599
Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
NCT06407232
Sparking Potential, Revealing Infant Neurocognitive Traits
NCT07390136
Sleep and Emotion Processing in Adolescent Post-traumatic Stress Disorder
NCT06341413
Oral and Swallowing Function in Older Adults
NCT06368830
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
NCT06305624
Rapalog Pharmacology (RAP PAC) Study
NCT05949658
Biomarkers to Detect Endocrine Therapy Resistance
NCT06067503
Outcomes and Cosmesis With Whole Breast Irradiation and Boost
NCT06295744
What is open in the University of Wisconsin, Madison pipeline
151 recruiting of 1,039 indexed (15% open); 712 completed (69%).
Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).
Top condition: Healthy (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Wisconsin, Madison: open-pipeline peers nationwide
Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,039 trials (± recruiting share)
- University of Washington · 1,048 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Masonic Cancer Center, University of Minnesota · 14% recruiting · 249 trials
- ModernaTX · 14% recruiting · 90 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
- The Cleveland Clinic · 14% recruiting · 688 trials
Related
What to do with this University of Wisconsin, Madison page
1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.
- 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets.Report a data error.